Viewing StudyNCT01881217



Ignite Creation Date: 2024-05-06 @ 1:45 AM
Last Modification Date: 2024-10-26 @ 11:08 AM
Study NCT ID: NCT01881217
Status: COMPLETED
Last Update Posted: 2017-09-14
First Post: 2013-06-17

Brief Title: First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced Refractory Solid Tumors
Sponsor: Bayer
Organization: Bayer

Conditions & Keywords Data

Conditions:
Name
Neoplasms
Keywords:
Name View
FGFR2 View
Phase I View
Dose escalation View
Advanced refractory solid tumors View